|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 109 studies with search of: | "Diabetic Nephropathies" |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Not yet recruiting |
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
|
||||
| 2 | Completed |
Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease
|
||||
| 3 | Completed |
Spironolactone in Diabetic Nephropathy
|
||||
| 4 | Completed |
Soy Protein in Early Diabetic Nephropathy
|
||||
| 5 | Completed |
Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
|
||||
| 6 | Terminated |
Effect of Sulodexide in Overt Diabetic Nephropathy
|
||||
| 7 | Completed |
Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy
|
||||
| 8 | Recruiting |
Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy
|
||||
| 9 | Completed |
Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy
|
||||
| 10 | Completed |
Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy
|
||||
| 11 | Completed |
Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy
|
||||
| 12 | Recruiting |
Nitric Oxide (NO) Activity and Diabetic Nephropathy
|
||||
| 13 | Completed |
Adiponectin and Insulin Resistance in Diabetic Nephropathy
|
||||
| 14 | Completed |
Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy
|
||||
| 15 | Completed |
Effect of Pyridorin in Patients With Diabetic Nephropathy
|
||||
| 16 | Completed |
Effect of Pyridorin in Patients With Diabetic Nephropathy
|
||||
| 17 | Recruiting |
Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN)
|
||||
| 18 | Not yet recruiting |
Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
|
||||
| 19 | Completed |
ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
|
||||
| 20 | Active, not recruiting |
Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|